Levels of the YKL-40 protein in boys and men with severe hemophilia A were higher in patients with joint damage, a study ...

This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.

Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...

With 2026 high school softball underway, we take a look at the veteran talent poised to lead area teams toward the OHSAA ...

One Roctavian dose prevented bleeds and the need for replacement therapy up to five years in most men with severe hemophilia A in Phase 3 trial.

We present a framework in which gravitation, inertia, and wave dynamics emerge from the response of a vacuum endowed with ...

Inflammatory pseudotumour of the liver (IPTL) is a rare benign lesion that can closely mimic hepatic malignancy on imaging ...